SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
15
Employees15
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
15
Employees15

SLS Key Statistics

Market cap
162.14M
Market cap162.14M
Price-Earnings ratio
-4.17
Price-Earnings ratio-4.17
Dividend yield
Dividend yield
Average volume
2.75M
Average volume2.75M
High today
High today
Low today
Low today
Open price
$1.59
Open price$1.59
Volume
0.00
Volume0.00
52 Week high
$2.12
52 Week high$2.12
52 Week low
$0.772
52 Week low$0.772

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.